HRS-2129 clinical trials
Also written HRS-2129.
How each study uses HRS-2129 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the HRS-2129 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2026 (3)
| Year | Studies |
|---|---|
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Studies
Open first, then newest update. How each study uses HRS-2129 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Clinical Study of HRS-2129 for Acute Gouty ArthritisRecruitingPhase 2Shandong Suncadia Medicine Co., Ltd.NCT07706777Written as HRS-2129 Tablet
- A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic PainRecruitingPhase 1Shandong Suncadia Medicine Co., Ltd.NCT07377721Written as HRS-2129 Tablets
- A Phase Ⅱ/Ⅲ Study of HRS-2129 for Postsurgical Pain Management in Abdominal SurgeryRecruitingPhase 2/3Shandong Suncadia Medicine Co., Ltd.NCT07185594Written as HRS-2129 Tablets
- A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee OsteoarthritisCompletedPhase 1Shandong Suncadia Medicine Co., Ltd.NCT07351968Written as HRS-2129 Tablet
- Clinical Study of HRS-2129 for Postoperative Analgesia in OrthopaedicsCompletedPhase 1/2Shandong Suncadia Medicine Co., Ltd.NCT06780267Written as HRS-2129
- A Multiple Ascending Dose Trial of HRS-2129 in Healthy SubjectsCompletedPhase 1Shandong Suncadia Medicine Co., Ltd.NCT06742840Written as HRS-2129
- A Single Dose Escalation Trial of HRS-2129 in Healthy SubjectsCompletedPhase 1Shandong Suncadia Medicine Co., Ltd.NCT06619392Written as HRS-2129